Litcius/Paper detail

AA amyloid fibrils from diseased tissue are structurally different from in vitro formed SAA fibrils

Akanksha Bansal, Matthias Schmidt, Matthies Rennegarbe, Christian Haupt, Falk Liberta, Sabrina Stecher, Ioana Puşcalău-Gîrţu, Alexander Biedermann, Marcus Fändrich

2021Nature Communications88 citationsDOIOpen Access PDF

Abstract

Systemic AA amyloidosis is a world-wide occurring protein misfolding disease of humans and animals. It arises from the formation of amyloid fibrils from serum amyloid A (SAA) protein. Using cryo electron microscopy we here show that amyloid fibrils which were purified from AA amyloidotic mice are structurally different from fibrils formed from recombinant SAA protein in vitro. Ex vivo amyloid fibrils consist of fibril proteins that contain more residues within their ordered parts and possess a higher β-sheet content than in vitro fibril proteins. They are also more resistant to proteolysis than their in vitro formed counterparts. These data suggest that pathogenic amyloid fibrils may originate from proteolytic selection, allowing specific fibril morphologies to proliferate and to cause damage to the surrounding tissue.

Topics & Concepts

FibrilAmyloid (mycology)In vitroProteolysisAmyloidosisChemistryAmyloid diseaseProtein aggregationAmyloid fibrilBiochemistryBiophysicsCell biologyBiologyPathologyAmyloid βEnzymeMedicineDiseaseInorganic chemistryAmyloidosis: Diagnosis, Treatment, OutcomesAlzheimer's disease research and treatmentsPrion Diseases and Protein Misfolding